Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Clinical Infectious Diseases

• Publication date

  2001-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1086/320869PMID 11389505
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative Study of Teicoplanin vs Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteraemia

  1996cited by this paper
• Effectiveness of Cloxacillin with and without Gentamicin in Short-Term Therapy for Right-Sided Staphylococcus aureus Endocarditis

  1996cited by this paper
• Right-sided endocarditis caused by Staphylococcus aureus in drug abusers

  1995cited by this paper
• Teicoplanin in endocarditis: a multicentre, open European study.

  1995cited by this paper
• Teicoplanin: a well-tolerated and easily administered alternative to vancomycin for Gram-positive infections in intensive care patients

  1994cited by this paper
• Glycopeptides and nephrotoxicity

  1994cited by this paper
• Effect of Human Serum on Killing Activity of Vancomycin and Teicoplanin against Staphylococcus aureus

  1994cited by this paper
• Dosage recommendations for teicoplanin.

  1993cited by this paper
• Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis

  1992cited by this paper
• Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis.

  1991cited by this paper
• Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts

  1991cited by this paper
• Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis

  1991cited by this paper
• Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon

  1991cited by this paper
• Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users

  1990cited by this paper
• Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin

  1990cited by this paper
• Nephrotoxicity of vancomycin, alone and with an aminoglycoside.

  1990cited by this paper
• Mild nephrotoxicity associated with vancomycin use.

  1989cited by this paper
• Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy.

  1988cited by this paper
• Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results.

  1988cited by this paper
• Comparison of pharmacokinetics and bactericidal activity of teicoplanin and vancomycin.

  1986cited by this paper
• Vancomycin therapy for infective endocarditis.

  1981cited by this paper
• Vancomycin therapy of bacterial endocarditis.

  1978cited by this paper
• Manual of clinical microbiology

  1975cited by this paper

• Antibiotic treatment duration for isolated methicillin-susceptible Staphylococcus aureus native tricuspid valve endocarditis: a standardized multidisciplinary approach

  2025cites this paper
• Endocardite infectieuse

  2023cites this paper
• Infectious endocarditis and infection of intracardiac devices in adults. Clinical guidelines 2021

  2022cites this paper
• A comparison of different antibiotic regimens for the treatment of infective endocarditis.

  2020cites this paper
• Infective Endocarditis in Persons Who Use Drugs: Epidemiology, Current Management, and Emerging Treatments.

  2020cites this paper
• A narrative review of early surgery versus conventional treatment for infective endocarditis: do we have an answer?

  2020cites this paper
• Infective endocarditis: trends, surgical outcomes, and controversies.

  2019cites this paper
• Staphylococcus aureus bacteraemia and endocarditis – epidemiology and outcome: a review

  2018cites this paper
• La endocarditis infecciosa del siglo XXI: una entidad distinta a la clásica?

  2018cites this paper
• Colouring outside the guidelines.

  2017cites this paper
• Old antimicrobials and Gram-positive cocci through the example of infective endocarditis and bone and joint infections.

  2017cites this paper
• Impact of rapid diagnosis of Staphylococcus aureus bacteremia from positive blood cultures on patient management

  2017cites this paper
• Challenges in Infective Endocarditis.

  2017cites this paper
• METHICILLINSUSCEPTIBLE STAPHYLOCOCCUS AUREUS PATHOGENICITY AND DRUG SUSCEPTIBILITY

  2017cites this paper
• A comparison of different antibiotic regimens for the treatment of infective endocarditis.

  2016cites this paper
• Changing Populations: The Elderly, Injection Drug Users, Health-Care Associated Endocarditis and Immunocompromised Patients

  2016cites this paper
• Right-Heart Endocarditis

  2016cites this paper
• Impact of routine bedside infectious disease consultation on clinical management and outcome of Staphylococcus aureus bacteraemia in adults

  2015cites this paper
• Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management

  2015cites this paper
• 82 – Endocarditis and Intravascular Infections

  2015cites this paper
• Bacteremia, Sepsis, and Infective Endocarditis Associated with Staphylococcus aureus.

  2015cites this paper
• Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association

  2015cites this paper
• Staphylococcus aureus bacteraemia - Disease progression and prognosis

  2014cites this paper
• Новые возможности лечения бактериемии и сепсиса вызванных стафилококками

  2014cites this paper
• [Subcutaneous teicoplanin for children with infectious endocarditis].

  2013cites this paper
• Srce i krvni Sudovi

  2013cites this paper
• Native valve right sided infective endocarditis.

  2013cites this paper
• Infectious Disease Consultation for Staphylococcus aureus Bacteremia Improves Patient Management and Outcomes

  2012cites this paper
• Role of intravenous cloxacillin for inpatient infections.

  2012cites this paper
• Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy.

  2012cites this paper
• Considerations of antibiotic therapy duration in community- and hospital-acquired bacterial infections.

  2012cites this paper
• Antibiotic therapy for treatment of infective endocarditis

  2012cites this paper
• Clinical Guideline for the Diagnosis and Treatment of Cardiovascular Infections

  2011cites this paper
• Strategies for reduction in duration of antibiotic use in hospitalized patients.

  2011cites this paper
• Clinical management of Staphylococcus aureus bacteraemia.

  2011cites this paper
• Postpartum culture negative endocarditis: a case report and review of the current guidelines

  2011cites this paper
• [Infective endocarditis: the role of surgery].

  2011cites this paper
• Complicated Community-Acquired Staphylococcus Endocarditis and Multiple Lung Abscesses: Case Report and Review of Literature

  2011cites this paper
• Is transesophageal echocardiography dispensable in hospital-acquired Staphylococcus aureus bacteremia?

  2011cites this paper
• Importancia actual de la bacteriemia por "staphylococcus aureus" en un hospital universitario

  2011cites this paper
• Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia

  2011cites this paper
• Endocarditis infecciosa: el papel de la cirugía

  2011cites this paper
• Glycopeptides (Vancomycin and Teicoplanin), Streptogramins (Quinupristin-Dalfopristin), and Lipopeptides (Daptomycin)

  2010cites this paper
• Consensus document on controversial issues in the diagnosis and treatment of bloodstream infections and endocarditis.

  2010influential citation
• Teicoplanin versus vancomycin for proven or suspected infection.

  2010cites this paper
• [Effective treatment of recurrent infective endocarditis. Is it always in compliance with the guidelines?].

  2010cites this paper
• The experience of surgery for isolated tricuspid valve infective endocarditis in intravenous drug abusers

  2010cites this paper
• Política de antimicrobianos do Hospital de Clínicas de Porto Alegre - 2010 : Comissão de Controle de Infecção Hospitalar

  2010cites this paper
• Active infective endocarditis: Clinical characteristics and factors related to hospital mortality.

  2010cites this paper
• Vancomycin MIC Susceptibility Testing of Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Isolates: A Comparison Between Etest® and an Automated Testing Method

  2010cites this paper
• New Perspectives of Infections in Cardiovascular Disease

  2009cites this paper
• Activities of Daptomycin and Vancomycin Alone and in Combination with Rifampin and Gentamicin against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus Isolates in an Experimental Model of Endocarditis

  2009cites this paper
• Activity of Telavancin against Staphylococcus aureus Strains with Various Vancomycin Susceptibilities in an In Vitro Pharmacokinetic/Pharmacodynamic Model with Simulated Endocardial Vegetations

  2009cites this paper
• Comparative Efficacy and Safety of Vancomycin versus Teicoplanin: Systematic Review and Meta-Analysis

  2009cites this paper
• Antistaphylococcal agents.

  2009cites this paper
• Staphylococcus aureus infections in hemodialysis: what a nephrologist should know.

  2009cites this paper
• New therapeutic choices for infections caused by methicillin-resistant Staphylococcus aureus.

  2009cites this paper
• Guía de práctica clínica para prevención, diagnóstico y tratamiento de la endocarditis infecciosa (nueva versión 2009)

  2009cites this paper
• Running Title: Daptomycin and vancomycin for biofilm-forming MRSA

  2009cites this paper
• Evaluation of Daptomycin Pharmacodynamics and Resistance at Various Dosage Regimens against Staphylococcus aureus Isolates with Reduced Susceptibilities to Daptomycin in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations

  2008cites this paper
• 53 - Traitement de l'endocardite bactérienne

  2008cites this paper
• The difference between adequate and appropriate antimicrobial treatment.

  2008cites this paper
• Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection.

  2008cites this paper
• Guía de tratamiento de la infección producida por Staphylococcus aureus resistente a meticilina

  2008cites this paper
• Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil.

  2008cites this paper
• [Guidelines for the treatment on infections caused by methicillin-resistant Staphylococcus aureus].

  2008cites this paper
• Bacterial endocarditis treated with intramuscular teicoplanin.

  2007cites this paper
• Medical treatment of endocarditis

  2007cites this paper
• Swedish guidelines for diagnosis and treatment of infective endocarditis

  2007cites this paper
• Aminoglycosides in Combination Therapy with ß-Lactam Antibiotics for Staphylococcus aureus Endocarditis: A Systematic Review

  2007cites this paper
• Infective endocarditis in drug addicts: role of HIV infection and the diagnostic accuracy of Duke criteria

  2007cites this paper
• Daptomicina: revitalizando un antiguo fármaco ante la necesidad de nuevos agentes activos frente a bacterias grampositivas multirresistentes

  2007cites this paper
• Impact of Empirical-Therapy Selection on Outcomes of Intravenous Drug Users with Infective Endocarditis Caused by Methicillin-Susceptible Staphylococcus aureus

  2007cites this paper
• Miscellaneous antibacterial drugs

  2007cites this paper
• The bactericidal effects of anti-MRSA agents with rifampicin and sulfamethoxazole-trimethoprim against intracellular phagocytized MRSA

  2007cites this paper
• Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia.

  2007cites this paper
• Antimicrobials for right-sided endocarditis in intravenous drug users: a systematic review.

  2007influential citation
• The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials.

  2006cites this paper
• Epidemiology and antibiotic treatment of infective endocarditis: an update

  2006cites this paper
• Treatment of intra-abdominal and skin and soft tissue infections: the role of the glycylcyclines.

  2006cites this paper
• Changing Populations: The Elderly, Injection Drug Users, Health-Care-Associated and Immunocompromised Patients

  2006cites this paper
• Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.

  2006cites this paper
• [Successful salvage of a patient with cardiac arrest caused by multiple pulmonary emboli and lung abscesses due to infective endocarditis of the tricuspid valve: a case report].

  2006cites this paper
• The surgical treatment of infective endocarditis: An overview

  2006cites this paper
• Update on infective endocarditis.

  2006cites this paper
• Epidemiology, treatment and outcome of Staphylococcus aureus bacteremia and endocarditis

  2006cites this paper
• endocarditis: an update Epidemiology and antibiotic treatment of infective

  2006cites this paper
• New agents for Staphylococcus aureus endocarditis

  2006cites this paper
• Comment on guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.

  2006cites this paper
• Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: A perspective for Canadian health care practitioners.

  2006cites this paper
• "Estudio de las complicaciones perianulares en la endocarditis infecciosa. Análisis de aspectos clínicos, microbiológicos, ecocardiográficos, terapéuticos y pronósticos en pacientes con abscesos perianulares y fístulas aorto-cavitarias en la endocarditis complicada."

  2005cites this paper
• Treatment Protocols for Bacterial Endocarditis and Infection of Electrophysiologic Cardiac Devices

  2005cites this paper
• Short-Course Gentamicin in Combination with Daptomycin or Vancomycin against Staphylococcus aureus in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations

  2005cites this paper
• Controversias en endocarditis infecciosas

  2005cites this paper
• Staphylococcus aureus infective endocarditis: diagnosis and management guidelines

  2005cites this paper
• Reply to Charles et al.

  2005cites this paper
• Rapid decrease of free vancomycin in dense staphylococcal cultures

  2005cites this paper
• Glycopeptide Antibacterials and the Treatment of Biofilm-Related Infections

  2005cites this paper
• In Vitro Killing of Community-Associated Methicillin-Resistant Staphylococcus aureus with Drug Combinations

  2004cites this paper
• Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy.

  2004cites this paper